Overview
Literature surveillance is an important tool in pharmacovigilance monitoring to ensure the safety and efficacy of products from clinical development stage through post-marketing. Research professionals face an increasingly complicated task due to the heightened level of scrutiny combined with the likelihood of high volumes of information from heterogeneous data sources.
Key Learning Objectives:
- Developing an adequate literature search strategy in support of regulatory compliance.
- Monitoring safety cases for diverse drug portfolios.
- The risk of conducting literature reviews manually.
- Identifying rare adverse events surveilling literature.
- Leveraging automation and standardised processes to streamline literature surveillance.
Speakers:
Andrew Purchase
Director of Pharmacovigilance Specialized Services and UK QPPV at ICON
Michael Braun-Boghos
Senior Director of Safety Strategy at Oracle Life Sciences
Moderated by Peter O’Blenis
CEO at DistillerSR